Latest Reimbursement News

Telix Pharmaceuticals reports positive Phase 3 results for its prostate cancer imaging agent Illuccix in China, paving the way for a near-term regulatory submission. Meanwhile, the company advances FDA resubmissions for its glioma and kidney cancer imaging candidates.

Cleo Diagnostics has raised $5 million to support the U.S. commercial launch of its Pre-Surgical Ovarian Cancer Test and accelerate development of a mass screening test, signaling strong investor confidence in its technology.

Sierra Nevada Gold (ASX – SNX) has won the rights to explore the expansive As Safra copper-gold project in Saudi Arabia, marking a strategic expansion into a high-potential mining district aligned with the Kingdom’s Vision 2030 ambitions.

Bulletin Resources has sold three non-core tenements of its Lake Rebecca Gold Project to Ramelius Resources for $500,000, enabling a strategic focus on its larger, recently acquired gold ground. The company remains well funded and is advancing exploration plans on high-potential targets.

Emyria has secured its first Empax clinic in Victoria, marking a significant step in its multi-state expansion and validating its scalable, reimbursed national mental health platform.

Adherium Limited reports a remarkable 103% quarter-on-quarter growth in Remote Patient Monitoring subscription revenues for Q2 FY26, driven by strong device shipment momentum and strategic operational changes.

Cue Energy Resources and partners have signed a Letter of Intent with the Northern Territory’s Power and Water Corporation to kickstart a four-well drilling program at Mereenie and Palm Valley, aiming for gas supply contracts through 2034.

Horizon Oil and its joint venture partners have signed a binding Letter of Intent with Northern Territory’s Power and Water Corporation to fast-track drilling of two new wells at Mereenie, aiming to secure long-term gas supply agreements through 2034.

Artrya Limited has begun generating fee-per-scan revenues from its Salix Coronary Plaque module at Tanner Health in the U.S., marking a key commercial milestone for the AI-powered cardiac imaging platform.

Emyria Limited is scaling up its Perth Empax clinic with increased therapist approvals and treatment rooms, setting the stage for broader national clinical growth next year.

Medallion Metals and IGO Limited have agreed to extend the deadline for completing the Forrestania Nickel Operation acquisition, allowing more time to meet key conditions and secure environmental approvals.

Matsa Resources has received an early A$1.5 million option fee payment from AngloGold Ashanti, reinforcing the latter’s commitment to the Lake Carey Gold Project and bringing total payments to A$7.2 million to date.